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ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2004.03.033Temporary perioperative cardiac pacing (TPCP) is indicated aftercardiac surgery for treatment of heart block or sinus bradycardia.1However, TPCP protocols are often arbitrary, lacking routines tomaximize cardiac output (CO) and stroke volume (SV). TPCP pa-rameters which can be optimized include heart rate (HR), ventricularpacing site (VPS), and atrioventricular delay (AVD). Also relevant is
variable right ventricular–left ventricular delay (RLD) which recently has become
available in some permanent pacemakers designed for biventricular pacing (BiVP).
Real-time measurement of SV with ultrasonic transit-time aortic flow probes
(UFPs)2 or arterial pulse contour systems make optimization of CO and SV during
changes in TPCP feasible. Dramatic and possibly life-saving benefits of TPCP
optimization have been anecdotally reported. Although the theory and practice of
TPCP optimization (POPT) will continue to advance, review of current information
can lead directly to patient benefits.
Background
The US Food and Drug Administration (FDA) has approved implantable pulse
generators for single-chamber atrial or ventricular (VVI) demand pacing, as well as
dual-chamber (DDD) generators that can maintain the physiologic synchrony of
atria and ventricles.1 Both endocardial (transvenous) and epicardial permanent leads
are available.1 A typical DDD system uses a single atrial lead and a single
ventricular lead. These leads are unipolar or bipolar (1 or 2 conductors). Unipolar
systems use the body as the indifferent electrode. Transvenous leads for DDD
pacing are usually placed in the right atrium (RA) and right ventricle (RV).
Epicardial leads are placed externally on the RA, RV, left atrium, or left ventricle
(LV). These leads sense intrinsic electrical activity and pace at low energy levels.
Implantable pacemakers are adjusted by using programmers that communicate with
generators through telemetry. For TPCP after cardiac surgery, temporary external
pacemakers are used with removable epicardial wires. Bipolar systems using 2 wires
to each chamber avoid common grounds and reduce sensing and pacing artifacts.
TPCP parameters are adjusted manually.
Recently, the FDA approved BiVP for congestive heart failure. BiVP is effective
in some patients with left ventricular dysfunction and QRS prolongation beyond 120
ms (intraventricular conduction delay [IVCD]). An IVCD and a left ventricular
ejection fraction (EF) of less than 35% often imply loss of synchrony of contraction
of the left ventricular free wall and septum.3 Clinical trials confirm that endocardial
pacing of the RV and LV (through a second pacing lead in a lateral branch of the
coronary sinus) narrows the QRS complex and significantly improves objective and
subjective measures of cardiac function in selected patients with dilated cardiomy-
opathy.4,5 Small trials indicate that BiVP can improve function while reducing
myocardial oxygen consumption (MVO2),6 that BiVP is most likely to be effective
in patients with very low EF and long IVCD of left bundle branch block configu-
ration,7 and that the efficacy of BiVP improves when the left ventricular pacing lead
is closest to the most delayed site of left ventricular contraction.3,8 Additional
studies suggest that endocardial BiVP might be effective in atrial fibrillation and
sinus rhythm9 and that BiVP reduces the severity of mitral regurgitation.10 The
efficacy of BiVP might be increased in some patients by incorporating a small
(20-80 ms) delay into the pacing algorithm, so that either the LV or RV is stimulated
first (DeLurgio DB, personal communication, 2003). The effect of AVD and RLD





Lis not consistent in any given patient. RLD optimization
more than doubled the improvement in SV obtained with
simultaneous RV-LV pacing in an unpublished substudy of
the Insync III trial (DeLurgio DB, personal communication).
With epicardial pacing, increasing HR can increase CO,
but the energy cost is also increased.11 Compared with VVI,
DDD epicardial pacing improves CO at any given HR.12
AVD has been shown to affect CO; this is patient specific
over a range of 100 to 225 ms.13 The variable effect of AVD
on CO is related in part to variable conduction times across
the atria and ventricles,14 as well as to intra-atrial conduc-
tion delays (IADS). CO is affected by the epicardial pacing
site.12,15,16 BiVP is effective with epicardial leads.17,18
BiVP might be effective in either right bundle branch block
or left bundle branch block, requiring protocols specific to
the conduction block.19 Epicardial BiVP might increase
arterial systolic pressure and reduce mitral regurgitation.18
BiVP might facilitate weaning of critically ill patients from
cardiopulmonary bypass.20 POPT and BiVP can improve
hemodynamics after operations for congenital heart dis-
ease.21-23 Benefits of BiVP after coronary artery bypass
grafting in patients with poor left ventricular function are
uncertain.24 In experimental animals epicardial DDD pacing
reduces MVO2 compared with VVI pacing.11 In human
subjects endocardial BiVP can improve ventricular function
and reduce MVO2, whereas inotropic agents increase MVO2.6
Pacing Protocols
TPCP at physiologic atrial rates typically involves tempo-
rary bipolar right atrial and right ventricular wires and a
DDD temporary pacemaker. VPS is the anterior or dia-
phragmatic RV. HR is usually 25% higher than physiologic
rate, and AVD is physiologic. Representative values in
adults are HR of 90 beats/min and AVD of 150 ms.
Heart Rate
The determinants of left ventricular SV are preload (left
ventricular end-diastolic volume), afterload (reflecting out-
flow resistance and ventricular dimensions), and contractile
state. Under physiologic conditions, considerable cardiac
reserve exists. During exercise, increased venous return can
increase preload, CO, and SV. However, cardiac reserve is
often diminished after cardiac surgery. Treatment of post-
operative low output states includes optimization of preload
(with volume administration), afterload (with vasodilators),
and contractility (with inotrope administration). Under these
circumstances, HR affects systolic or mean arterial pressure
(MAP) through several mechanisms. Theoretically, CO 
MAP/R, where R is arterial resistance. Thus increases in CO
and MAP are linearly related until R is affected by reflex
changes (Prasso and colleagues, manuscript in preparation).
On the other hand, systolic pressure reflects both MAP and
pulse pressure, and pulse pressure is affected by SV. If HR
6 The Journal of Thoracic and Cardiovascular Surgery ● Januaris cut in half and CO remains constant, SV must double, and
systolic pressure will increase. For this reason, MAP is
more reliable than systolic blood pressure in POPT.
Atrioventricular Delay
DDD protocols optimize ventricular filling by synchroniz-
ing the onset of ventricular systole with completion of the
atrial kick. For patients with regular atrial rhythm, AVD
begins with right atrial depolarization or stimulation and
ends when the RV depolarizes or is stimulated. The AVD in
a permanent pacemaker is typically 150 ms during atrial
sensing and 200 ms during atrial pacing. The differential of
50 ms allows for IAD, the interval between the atrial pacing
stimulus and the P wave. IADs are prolonged to 150 to 200
ms in some patients. A prolonged IAD of 200 ms combined
with an AVD of 200 ms will result in simultaneous right
atrial and right ventricular contraction, negating the atrial
kick. Variable IAD and variable conduction time from the
RA to the left atrium and atrioventricular node to the RV
and the LV require AVD optimization.
Recommendations
POPT begins with CO measurement. Many techniques are
available for this, but real-time SV by UFP best facilitates
POPT. On the downside, application and removal of UFPs
requires some manipulation of the ascending aorta. Fluid
immersion of the UFP and aorta maximizes ultrasound
transmission and data reliability. CO varies with respiration;
averaging data over one complete respiratory cycle is most
meaningful. Alternative methods for measuring changes in
CO include arterial pulse contour systems (Berberian and
coworkers, manuscript in preparation), thermal or indicator
dilution, ventricular conductance, echo-Doppler, Fick deter-
minations,22,23 or mixed venous oxygen saturation in the
RA. Changes in arterial blood pressure can be useful; MAP
is most closely related to CO (Prasso and colleagues, manu-
script in preparation).
During TPCP for sinus bradycardia or heart block, POPT
involves simply maximizing CO. HR is usually determined
by means of clinical assessment of benefits of HR-depen-
dent increases in CO versus detrimental effects of decreased
diastolic filling time and possible subendocardial ischemia.
Converting VPS from the RV to a biventricular state can
increase CO in this setting. Temporary epicardial wires can
be added to the obtuse margin of the LV. After identifying
which lead of the pair has the lowest threshold, BiVP is
implemented by bringing the best right ventricular and left
ventricular leads to the negative terminal of a temporary
pacemaker; the other pair is combined at the positive ter-
minal. If the patient’s body is used as the ground, the
myocardial wires should be combined at the negative ter-
minal, and the patient’s body should be connected to the
positive terminal. The output of the temporary pacemaker








Lleft ventricular threshold, whichever is higher. Paired tem-
porary atrial wires should be connected as usual. We find
these maneuvers consistently increase CO by 10% or more
in patients with physiologic atrial rates after valve replace-
ment surgery. In some patients, the improvement is 20% to
30%. BiVP effects on CO can be quickly tested and a
clinical decision reached on whether continuation is war-
ranted, considering a small risk of bleeding on removal of
the left ventricular wires. If the benefit does not warrant the
risk, the left ventricular wires can be removed. The im-
provement in CO with BiVP is so consistent that it might
reflect reversal of the detrimental effects of single-site right
ventricular pacing in most instances.
The relationship between AVD and CO is curvilinear,
with CO decreasing at AVDs shorter than 100 ms or longer
than 200 ms. Exceptions are common in advanced heart
failure, and objective testing can overcome errors of con-
ventional recommendations. With a long IAD, very long
AVDs might be needed for POPT.
RLD is not currently available in temporary pacemakers
but is available in some FDA-approved BiVP generators. If
permanent BiVP is clinically indicated, it can be imple-
mented with epicardial leads at the conclusion of cardiopul-
monary bypass. If this is done, the optimization sequence
should be AVD first and then RLD at the optimum AVD.
An RLD that results in right ventricular stimulation first is
most likely to benefit patients with primary right ventricular
dysfunction,25-27 whereas the LV first should be favored in
left ventricular dysfunction. At present, no reliable guide-
lines for POPT after cardiac surgery have been developed.
The stability of POPT over time is uncertain and could
require frequent cycles of measurement and adjustment.
Pacing for Heart Failure
BiVP might prove valuable in patients undergoing cardiac
surgery with advanced preoperative ventricular dysfunction
and an IVCD. Little is known about the risks and benefits of
pacing for heart failure after cardiac surgery in patients with
no other indication. The importance of low EF and IVCD in
this setting are largely unproved. Early studies demonstrate
beneficial effects of multisite pacing in congenital heart
disease with right bundle branch block.22,23 Until more
information and FDA-approved devices are available, stud-
ies of BiVP are best conducted with institutional review
board protocols and informed consent.
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